99 Episodo

  1. RANO resect

    Publicado: 23/6/2023

  2. Methylation profiling of adult ependymoma

    Publicado: 9/6/2023

  3. Pseudoprogression in IDH-mutant high-grade gliomas

    Publicado: 12/5/2023

  4. Changes in survival outcomes in melanoma patients with brain metastases

    Publicado: 21/4/2023

  5. Radiation therapy and structural brain changes

    Publicado: 7/4/2023

  6. Objective response rate targets for recurrent glioblastoma clinical trials

    Publicado: 17/3/2023

  7. Mitotic count prognostic significance in IDH-mutant astrocytoma in the molecular era

    Publicado: 3/3/2023

  8. Palliative care in neuro-oncology

    Publicado: 10/2/2023

  9. Nivolumab in MGMT methylated GBM

    Publicado: 27/1/2023

  10. IDH mutant gliomas; SNO consensus Review

    Publicado: 13/1/2023

  11. DNA methylation subclass and extent of GBM resection

    Publicado: 30/12/2022

  12. Pre-operative [11C]methionine PET for low-grade glioma

    Publicado: 16/12/2022

  13. The role of T lymphocytes in the glioma pathobiology

    Publicado: 2/12/2022

  14. CDKN2A homozygous deletion in IDH mutant astrocytoma

    Publicado: 8/10/2022

  15. EGFR: the lazarus target in glioblastom

    Publicado: 23/9/2022

  16. Brain metastases; a SNO consensus review: Part 2

    Publicado: 9/9/2022

  17. Brain metastases; a SNO consensus review: Part 1

    Publicado: 26/8/2022

  18. Pediatric IDH mutant gliomas

    Publicado: 13/8/2022

  19. Low-risk meningioma: Outcomes from NRG 0539

    Publicado: 29/7/2022

  20. Selumetinib in children with NF1 and plexiform neurofibroma

    Publicado: 1/7/2022

3 / 5

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

Visit the podcast's native language site